Transition from obesity to metabolic syndrome is associated with altered myocardial autophagy and apoptosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 5, 2012, Pages 1132-1141

  Li, Zi Lun ^a,b   Woollard, John R ^a   Ebrahimi, Behzad ^a   Crane, John A ^a   Jordan, Kyra L ^a   Lerman, Amir ^a   Wang, Shen Ming ^b   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Autophagy; Cardiac function; Inflammation; Metabolic syndrome; Obesity

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROGENIC DIET; AUTOPHAGY; CONTROLLED STUDY; DYSLIPIDEMIA; ENERGY METABOLISM; EXPERIMENTAL PIG; HEART FUNCTION; HEART HEMODYNAMICS; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE PERFUSION; HEART OUTPUT; HISTOPATHOLOGY; HYPOXIA; IMMUNOBLOTTING; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; MICROCIRCULATION; MITOCHONDRION; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OXIDATIVE STRESS; OXYGEN BLOOD LEVEL; OXYGENATION; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; AUTOPHAGY; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; MYOCARDIUM; OBESITY; OXIDATIVE STRESS; SWINE;

EID: 84862823783     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.244061     Document Type: Article

References (52)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303:235-241.
2. Cornier MA, Marshall JA, Hill JO, Maahs DM, Eckel RH. Prevention of overweight/obesity as a strategy to optimize cardiovascular health. Circulation. 2011;124:840-850.
3. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362-2374. (Pubitemid 38702847)
4. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689. (Pubitemid 32893993)
5. de las Fuentes L, Brown AL, Mathews SJ, Waggoner AD, Soto PF, Gropler RJ, Davila-Roman VG. Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur Heart J. 2007;28:553-559. (Pubitemid 47355514)
6. Xu HY, Barnes GT, Yang Q, Tan Q, Yang DS, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821-1830. (Pubitemid 38063705)
7. Ko HJ, Zhang ZY, Jung DY, Jun JY, Ma ZX, Jones KE, Chan SY, Kim JK. Nutrient stress activates inflammation and reduces glucose metabolism by suppressing amp-activated protein kinase in the heart. Diabetes. 2009;58:2536-2546.
8. Panchal SK, Poudyal H, Iyer A, Nazer R, Alam MA, Diwan V, Kauter K, Sernia C, Campbell F, Ward L, Gobe G, Fenning A, Brown L. High-carbohydrate high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol. 2011;57:51-64.
9. Nemchenko A, Chiong M, Turer A, Lavandero S, Hill JA. Autophagy as a therapeutic target in cardiovascular disease. J Mol Cell Cardiol. 2011;51:584-593.
10. Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, Bauer EP, Klovekorn WP, Schaper J. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart-structural deterioration and compensatory mechanisms. Circulation. 2003;107:984-991. (Pubitemid 36258721)
11. Zhu HX, Tannous P, Johnstone JL, Kong YL, Shelton JM, Richardson JA, Lei V, Levine B, Rothermel BA, Hill JA. Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest. 2007;117:1782-1793. (Pubitemid 47036312)
12. Glazer HP, Osipov RM, Clements RT, Sellke FW, Bianchi C. Hypercholesterolemia is associated with hyperactive cardiac mtorc1 and mTORC2 signaling. Cell Cycle. 2009;8:1738-1746.
13. Yang L, Li P, Fu SN, Calay ES, Hotamisligil GS. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 2010;11:467-478.
14. Menzies KJ, Hood DA. The role of SIRT1 in muscle mitochondrial turnover. Mitochondrion. 2011;In press.
15. Zhou LJ, Liu F. Autophagy roles in obesity-induced ER stress and adiponectin downregulation in adipocytes. Autophagy. 2010;6:1196-1197.
16. Mellor KM, Bell JR, Young MJ, Ritchie RH, Delbridge LMD. Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice. J Mol Cell Cardiol. 2011;50:1035-1043.
17. Dyson MC, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M. Components of metabolic syndrome and coronary artery disease in female ossabaw swine fed excess atherogenic diet. Comp Med. 2006;56:35-45.
18. Li Z, Woollard JR, Wang S, Korsmo MJ, Ebrahimi B, Grande JP, Textor SC, Lerman A, Lerman LO. Increased glomerular filtration rate in early metabolic syndrome is associated with renal adiposity and microvascular proliferation. Am J Physiol Renal Physiol. 2011;301:F1078-F1087.
19. Galili O, Versari D, Sattler KJ, Olson ML, Mannheim D, McConnell JP, Chade AR, Lerman LO, Lerman A. Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am J Physiol-Heart Circul Physiol. 2007;292:H904-H911.
20. Zhu XY, Daghini E, Chade AR, Napoli C, Ritman EL, Lerman A, Lerman LO. Simvastatin prevents coronary microvascular remodeling in renovascular hypertensive pigs. J Am Soc Nephrol. 2007;18:1209-1217. (Pubitemid 46536907)
21. Warner L, Glockner JF, Woollard J, Textor SC, Romero JC, Lerman LO. Determinations of renal cortical and medullary oxygenation using blood oxygen level-dependent magnetic resonance imaging and selective diuretics. Invest Radiol. 2011;46:41-47.
22. Urbieta Caceres VH, Lin J, Zhu XY, Favreau FD, Gibson ME, Crane JA, Lerman A, Lerman LO. Early experimental hypertension preserves the myocardial microvasculature but aggravates cardiac injury distal to chronic coronary artery obstruction. Am J Physiol-Heart Circul Physiol. 2011;300:H693-H701.
23. Zhu XY, Daghini E, Chade AR, Versari D, Krier JD, Textor KB, Lerman A, Lerman LO. Myocardial microvascular function during acute coronary artery stenosis: effect of hypertension and hypercholesterolaemia. Cardiovasc Res. 2009;83:371-380.
24. Rodriguez-Porcel M, Lerman A, Ritman EL, Wilson SH, Best PJM, Lerman LO. Altered myocardial microvascular 3D architecture in experimental hypercholesterolemia. Circulation. 2000;102:2028-2030.
25. Zhu XY, Rodriguez-Porcel M, Bentley MD, Chade AR, Sica V, Napoli C, Caplice N, Ritman EL, Lerman A, Lerman LO. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation. 2004;109:2109-2115. (Pubitemid 38620220)
26. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840-846. (Pubitemid 46024990)
27. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440:944-948.
28. Zhang XQ, Zhang RL, Raab S, Zheng W, Wang J, Liu N, Zhu TG, Xue LF, Song ZT, Mao JM, Li KT, Zhang HL, Zhang Y, Han C, Ding Y, Wang H, Hou N, Liu YL, Shang SJ, Li CY, Sebokova E, Cheng HP, Huang PL. Rhesus macaques develop metabolic syndrome with reversible vascular dysfunction responsive to pioglitazone. Circulation. 2011;124:77-86.
29. Lakhani M, Fein S. Effects of obesity and subsequent weight reduction on left ventricular function. Cardiol Rev. 2011;19:1-4.
30. Oliveira Junior SA, Dal Pai-Silva M, Martinez PF, Lima-Leopoldo AP, Campos DH, Leopoldo AS, Okoshi MP, Okoshi K, Padovani CR, Cicogna AC. Diet-induced obesity causes metabolic, endocrine and cardiac alterations in spontaneously hypertensive rats. Med Sci Monit. 2010;16:367-373.
31. Ruberg FL, Chen ZJ, Hua N, Bigornia S, Guo ZF, Hallock K, Jara H, LaValley M, Phinikaridou A, Qiao Y, Viereck J, Apovian CM, Hamilton JA. The relationship of ectopic lipid accumulation to cardiac and vascular function in obesity and metabolic syndrome. Obesity. 2010;18:1116-1121.
32. Glenn DJ, Wang F, Nishimoto M, Cruz MC, Uchida Y, Holleran WM, Zhang Y, Yeghiazarians Y, Gardner DG. A murine model of isolated cardiac steatosis leads to cardiomyopathy. Hypertension. 2011;57:216-222.
33. Zhang YM, Ren J. Role of cardiac steatosis and lipotoxicity in obesity cardiomyopathy. Hypertension. 2011;57:148-150.
34. Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JWA, Bax JJ, Romijn JA, de Roos A, Radder JK. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol. 2003;42:328-335. (Pubitemid 36851426)
35. de Kreutzenberg SV, Ceolotto G, Papparella I, Bortoluzzi A, Semplicini A, Dalla Man C, Cobelli C, Fadini GP, Avogaro A. Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: Potential biochemical mechanisms. Diabetes. 2010;59:1006-1015.
36. Liang HY, Ward WF. Pgc-1 alpha: A key regulator of energy metabolism. Adv Physiol Educ. 2006;30:145-151. (Pubitemid 44749372)
37. Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy. J Am Coll Cardiol. 2008;51:93-102.
38. Arany Z, He HM, Lin JD, Hoyer K, Handschin C, Toka O, Ahmad F, Matsui T, Chin S, Wu PH, Rybkin II, Shelton JM, Manieri M, Cinti S, Schoen FJ, Bassel-Duby R, Rosenzweig A, Ingwall JS, Spiegelman BM. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab. 2005;1:259-271. (Pubitemid 43960608)
39. Guerrero-Ontiveros ML, Wallimann T. Creatine supplementation in health and disease. Effects of chronic creatine ingestion in vivo: down-regulation of the expression of creatine transporter isoforms in skeletal muscle. Mol Cell Biochem. 1998;184:427-437. (Pubitemid 28398625)
40. Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB, Wilson PWF. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care. 2007;30:1219-1225. (Pubitemid 46684651)
41. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999;79:215-262. (Pubitemid 29056953)
42. Zhu XY, Daghini E, Rodriguez-Porcel M, Chade AR, Napoli C, Lerman A, Lerman LO. Redox-sensitive myocardial remodeling and dysfunction in swine diet-induced experimental hypercholesterolemia. Atherosclerosis. 2007;193:62-69. (Pubitemid 46776711)
43. Sobel BE, Schneider DJ, Lee YH, Pratley RE. Insulin resistance increases PAI-1 in the heart. Biochem Biophys Res Commun. 2006;346:102-107. (Pubitemid 43865973)
44. Iliescu R, Chade AR. Progressive renal vascular proliferation and injury in obese zucker rats. Microcirculation. 2010;17:250-258.
45. Ghosh HS, McBurney M, Robbins PD. SIRT1 negatively regulates the mammalian target of rapamycin. PLoS One. 2010;5:e9199.
46. Koga H, Kaushik S, Cuervo AM. Altered lipid content inhibits autophagic vesicular fusion. Faseb J. 2010;24:3052-3065.
47. Harris J, De Haro SA, Master SS, Keane J, Roberts EA, Delgado M, Deretic V. T helper 2 cytokines inhibit autophagic control of intracellular mycobacterium tuberculosis. Immunity. 2007;27:505-517. (Pubitemid 47418681)
48. Boya P, Gonzalez-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N, Metivier D, Meley D, Souquere S, Yoshimori T, Pierron G, Codogno P, Kroemer G. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol. 2005;25:1025-1040. (Pubitemid 40165810)
49. Derdak Z, Lang CH, Villegas KA, Tong M, Mark NM, de la Monte SM, Wands JR. Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease. J Hepatol. 2011;54:164-172.
50. Alkhouri N, Gornicka A, Berk MP, Thapaliya S, Dixon LJ, Kashyap S, Schauer PR, Feldstein AE. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J Biol Chem. 2010;285:3428-3438.
51. Katare RG, Caporali A, Oikawa A, Meloni M, Emanueli C, Madeddu P. Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1-mediated survival pathway. Circ-Heart Fail. 2010;3:294-305.
52. Rajesh M, Mukhopadhyay P, Batkai S, Patel V, Saito K, Matsumoto S, Kashiwaya Y, Horvath B, Mukhopadhyay B, Becker L, Hasko G, Liaudet L, Wink DA, Veves A, Mechoulam R, Pacher P. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol. 2010;56:2115-2125.